Gastric Insufflation and Laryngeal Mask Airway
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2014
CompletedFirst Posted
Study publicly available on registry
March 27, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedNovember 19, 2014
November 1, 2014
8 months
March 21, 2014
November 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of gastric insufflation
during pulmonary ventilation through the laryngeal mask airway
Study Arms (2)
LMA SupremeTM
ACTIVE COMPARATORAmbu AuraOnce
SHAM COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- ASA 1 or 2
- Age \> 18 yrs
- Use of laryngeal mask airway required
You may not qualify if:
- risk of pulmonary aspiration of gastric contents
- Contraindication for the use of laryngeal mask airway
- Tracheal intubation required
- Patient's refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lionel Bouvetlead
Study Sites (1)
Hospices Civils de Lyon
Lyon, 69003, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
March 21, 2014
First Posted
March 27, 2014
Study Start
November 1, 2014
Primary Completion
July 1, 2015
Last Updated
November 19, 2014
Record last verified: 2014-11